Form 8-K - Current report:
SEC Accession No. 0001842952-25-000051
Filing Date
2025-06-02
Accepted
2025-06-02 07:34:15
Documents
52
Period of Report
2025-06-02
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cntx-20250602.htm   iXBRL 8-K 25021
2 EX-99.1 a2025june-contextxcorpde.htm EX-99.1 45470
6 a2025june-contextxcorpde001.jpg GRAPHIC 53879
7 a2025june-contextxcorpde002.jpg GRAPHIC 218502
8 a2025june-contextxcorpde003.jpg GRAPHIC 110688
9 a2025june-contextxcorpde004.jpg GRAPHIC 114320
10 a2025june-contextxcorpde005.jpg GRAPHIC 66504
11 a2025june-contextxcorpde006.jpg GRAPHIC 81022
12 a2025june-contextxcorpde007.jpg GRAPHIC 122604
13 a2025june-contextxcorpde008.jpg GRAPHIC 117570
14 a2025june-contextxcorpde009.jpg GRAPHIC 66185
15 a2025june-contextxcorpde010.jpg GRAPHIC 67497
16 a2025june-contextxcorpde011.jpg GRAPHIC 100401
17 a2025june-contextxcorpde012.jpg GRAPHIC 84694
18 a2025june-contextxcorpde013.jpg GRAPHIC 111226
19 a2025june-contextxcorpde014.jpg GRAPHIC 114342
20 a2025june-contextxcorpde015.jpg GRAPHIC 99375
21 a2025june-contextxcorpde016.jpg GRAPHIC 131413
22 a2025june-contextxcorpde017.jpg GRAPHIC 97881
23 a2025june-contextxcorpde018.jpg GRAPHIC 82439
24 a2025june-contextxcorpde019.jpg GRAPHIC 67057
25 a2025june-contextxcorpde020.jpg GRAPHIC 108085
26 a2025june-contextxcorpde021.jpg GRAPHIC 104838
27 a2025june-contextxcorpde022.jpg GRAPHIC 93762
28 a2025june-contextxcorpde023.jpg GRAPHIC 90627
29 a2025june-contextxcorpde024.jpg GRAPHIC 94070
30 a2025june-contextxcorpde025.jpg GRAPHIC 102032
31 a2025june-contextxcorpde026.jpg GRAPHIC 132052
32 a2025june-contextxcorpde027.jpg GRAPHIC 96838
33 a2025june-contextxcorpde028.jpg GRAPHIC 91475
34 a2025june-contextxcorpde029.jpg GRAPHIC 67530
35 a2025june-contextxcorpde030.jpg GRAPHIC 108837
36 a2025june-contextxcorpde031.jpg GRAPHIC 109469
37 a2025june-contextxcorpde032.jpg GRAPHIC 106129
38 a2025june-contextxcorpde033.jpg GRAPHIC 97479
39 a2025june-contextxcorpde034.jpg GRAPHIC 96678
40 a2025june-contextxcorpde035.jpg GRAPHIC 64378
41 a2025june-contextxcorpde036.jpg GRAPHIC 80081
42 a2025june-contextxcorpde037.jpg GRAPHIC 60173
43 a2025june-contextxcorpde038.jpg GRAPHIC 51744
44 a2025june-contextxcorpde039.jpg GRAPHIC 96040
  Complete submission text file 0001842952-25-000051.txt   5396735

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cntx-20250602.xsd EX-101.SCH 1818
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cntx-20250602_lab.xml EX-101.LAB 24372
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cntx-20250602_pre.xml EX-101.PRE 14143
54 EXTRACTED XBRL INSTANCE DOCUMENT cntx-20250602_htm.xml XML 3001
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40654 | Film No.: 251013146
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)